$3.96
-0.11[-2.70%]
At close: Apr 30
$3.96
0[0.00%]
After Hours: 4:00PM EDT
Bioventus
(NASDAQ:BVS)Latest News for Bioventus Stock (NASDAQ:BVS)
Bioventus Stock (NASDAQ: BVS)
Categories: All
Friday, March 15, 2024
Wednesday, March 13, 2024
Tuesday, March 12, 2024
- Why Asana Shares Are Trading Lower By 11%? Here Are Other Stocks Moving In Tuesday's Mid-Day SessionAvi Kapoor - Mar 12, 2024, 2:07PM
- Bioventus Reports Upbeat Earnings, Joins Ranpak, Beachbody And Other Big Stocks Moving Higher On TuesdayAvi Kapoor - Mar 12, 2024, 10:37AM
- 12 Health Care Stocks Moving In Tuesday's Pre-Market SessionBenzinga Insights - Mar 12, 2024, 9:05AM
- Bioventus shares are trading higher after the company reported better-than-expected Q4 financial results and issued FY24 net sales guidance above estimates.Benzinga Newsdesk - Mar 12, 2024, 7:58AM
- Bioventus Expects FY24 Net Sales of $520M-$535M Vs $517.82M Est, Adj EPS of EPS of $0.12-$0.20 Vs $0.33 EstBenzinga Newsdesk - Mar 12, 2024, 7:56AM
- Bioventus Expects 2024 Sales Of $520M-$535M Versus Consensus Of $517.74M, With Adjusted EPS Of $0.12-$0.20 Versus Consensus Of $0.33 And Adjusted EBITDA Of $89M-$94MBenzinga Newsdesk - Mar 12, 2024, 7:54AM
- Bioventus Q4 Adjusted EPS $0.07 Beats $0.02 Estimate, Sales $135.42M Beat $123.96M EstimateBenzinga Newsdesk - Mar 12, 2024, 7:51AM
- Earnings Scheduled For March 12, 2024Benzinga Insights - Mar 12, 2024, 5:35AM
Monday, March 11, 2024
Tuesday, December 19, 2023
Thursday, December 07, 2023
Wednesday, December 06, 2023
Tuesday, November 07, 2023
- Bioventus Sees FY23 EPS $(0.12)-$(0.09) Vs $(0.19) Est.; Revenue $498M-$505M Vs $499.79M Est.Benzinga Newsdesk - Nov 7, 2023, 8:51AM
- Bioventus Q3 Adj EPS $0.05 Misses $0.06 Estimate, Sales $120.79M Beat $120.34M EstimateBenzinga Newsdesk - Nov 7, 2023, 7:13AM
- Earnings Scheduled For November 7, 2023Benzinga Insights - Nov 7, 2023, 6:34AM
Monday, November 06, 2023
Wednesday, August 23, 2023
Thursday, August 17, 2023
Wednesday, August 16, 2023
Tuesday, August 15, 2023
Tuesday, August 08, 2023
- Bioventus Sees FY23 Adj. EPS $(0.24)-$(0.20), Revenue $490M-$505MBenzinga Newsdesk - Aug 8, 2023, 7:32AM
- Bioventus Q2 Adj. EPS $0.14 Beats $0.03 Estimate, Sales $137.10M Beat $128.90M EstimateBenzinga Newsdesk - Aug 8, 2023, 7:32AM
- Earnings Scheduled For August 8, 2023Benzinga Insights - Aug 8, 2023, 4:48AM
Monday, August 07, 2023
Tuesday, June 20, 2023
Thursday, June 15, 2023
Tuesday, June 06, 2023
Tuesday, May 30, 2023
Thursday, May 25, 2023
Wednesday, May 24, 2023
Tuesday, May 16, 2023
- Recap: Bioventus Q1 EarningsBenzinga Insights - May 16, 2023, 4:25PM
- Bioventus Q1 Adj EPS From Cont Ops $(0.26) Misses $(0.15) Estimate, Sales $119.06M Beat $116.58M EstimateBenzinga Newsdesk - May 16, 2023, 4:20PM
- Last Evening, Bioventus Rescheduled Reporting Of Q1 Results To After Market Close On May 16, 2023; Expects To Report Revenue Of $119M, Adjusted EBITDA Of $17MBenzinga Newsdesk - May 16, 2023, 5:13AM
Monday, May 15, 2023
Thursday, May 11, 2023
Wednesday, April 05, 2023
Monday, April 03, 2023
Friday, March 31, 2023
- Why Y-mAbs Therapeutics Shares Are Trading Higher By 50%? Here Are Other Stocks Moving In Friday's Mid-Day SessionLisa Levin - Mar 31, 2023, 12:47PM
- Bioventus shares are trading lower after the company reported worse-than-expected Q4 adjusted EPS and sales results.Benzinga Newsdesk - Mar 31, 2023, 12:31PM
- Stocks That Hit 52-Week Lows On FridayBenzinga Insights - Mar 31, 2023, 11:46AM
- Last Day Of Q1GRIT Capital - Mar 31, 2023, 10:18AM
- Bioventus Q4 Adj EPS $(0.06) Misses $0.05 Estimate, Sales $125.83M Miss $132.70M EstimateBenzinga Newsdesk - Mar 31, 2023, 7:54AM
- Bioventus Announces Amendment With Its Credit Agreement Lenders To Enhance Financial And Operational FlexibilityBenzinga Newsdesk - Mar 31, 2023, 7:02AM
- Earnings Scheduled For March 31, 2023Benzinga Insights - Mar 31, 2023, 4:45AM